Page 65 - Read Online

Persico et al. Rare Dis Orphan Drugs J 2023;2:xx https://dx.doi.org/10.20517/rdodj.2023.08 Page 21 of 21

67. Chauhan A, Audhya T, Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem Res 2012; 37:1681-9.
DOI PubMed
68. Rose S, Melnyk S, Pavliv O, et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the
autism brain. Transl Psychiatry 2012; 2:e134. DOI PubMed PMC
69. Frustaci A, Neri M, Cesario A, et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic
Biol Med 2012; 52:2128-41. DOI
70. Tang G, Gutierrez Rios P, Kuo SH, et al. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis 2013; 54:349-
61. DOI PubMed PMC
71. Gu F, Chauhan V, Chauhan A. Impaired synthesis and antioxidant defense of glutathione in the cerebellum of autistic subjects:
alterations in the activities and protein expression of glutathione-related enzymes. Free Radic Biol Med 2013; 65:488-96. DOI
PubMed
72. El-Ansary A, Bjørklund G, Chirumbolo S, Alnakhli OM. Predictive value of selected biomarkers related to metabolism and oxidative
stress in children with autism spectrum disorder. Metab Brain Dis 2017; 32:1209-21. DOI PubMed
73. Yenkoyan K, Harutyunyan H, Harutyunyan A. A certain role of SOD/CAT imbalance in pathogenesis of autism spectrum disorders.
Free Radic Biol Med 2018; 123:85-95. DOI
74. Adams JB, Baral M, Geis E, et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione
levels. J Toxicol 2009; 2009:532640. DOI PubMed PMC
75. Ghezzo A, Visconti P, Abruzzo PM, et al. Oxidative stress and erythrocyte membrane alterations in children with autism: correlation
with clinical features. PLoS One 2013;8:e66418. DOI PubMed PMC
76. Gorrindo P, Lane CJ, Lee EB, McLaughlin B, Levitt P. Enrichment of elevated plasma F2t-isoprostane levels in individuals with
autism who are stratified by presence of gastrointestinal dysfunction. PLoS One 2013;8:e68444. DOI PubMed PMC
77. Rose S, Bennuri SC, Murray KF, Buie T, Winter H, Frye RE. Mitochondrial dysfunction in the gastrointestinal mucosa of children
with autism: a blinded case-control study. PLoS One 2017;12:e0186377. DOI PubMed PMC
78. McElhanon BO, McCracken C, Karpen S, Sharp WG. Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis.
Pediatrics 2014;133:872-83. DOI PubMed
79. Frye RE, Cox D, Slattery J, et al. Mitochondrial dysfunction may explain symptom variation in phelan-mcdermid syndrome. Sci Rep
2016;6:19544. DOI PubMed PMC
80. Naviaux RK. Oxidative shielding or oxidative stress? J Pharmacol Exp Ther 2012;342:608-18. DOI PubMed
81. Adams JB, Holloway C. Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder.
J Altern Complement Med 2004;10:1033-9. DOI PubMed
82. Adams JB, Audhya T, McDonough-Means S, et al. Effect of a vitamin/mineral supplement on children and adults with autism. BMC
Pediatr 2011;11:111. DOI PubMed PMC
83. Adams JB, Audhya T, Geis E, et al. Comprehensive nutritional and dietary intervention for autism spectrum disorder-a randomized,
controlled 12-month trial. Nutrients 2018;10:369. DOI PubMed PMC
84. Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L. A preliminary trial of ascorbic acid as supplemental therapy for autism.
Prog Neuropsych Biol Psychiatry 1993;17:765-74. DOI
85. Adams JB, George F, Audhya T. Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements
compared to controls not taking supplements. J Altern Complement Med 2006;12:59-63. DOI
86. Mousavinejad E, Ghaffari MA, Riahi F, Hajmohammadi M, Tiznobeyk Z, Mousavinejad M. Coenzyme Q(10) supplementation
reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Res
2018;265:62-9. DOI PubMed
87. Eldridge SM, Chan CL, Campbell MJ, et al; PAFS consensus group. CONSORT 2010 statement: extension to randomised pilot and
feasibility trials. Pilot Feasibility Stud 2016;2:64. DOI PubMed PMC
88. Matuleviciene A, Siauryte K, Kuiper E, Grabrucker AM; European Phelan-McDermid syndrome guideline consortium. Consensus
recommendations on chewing, swallowing and gastrointestinal problems in Phelan-McDermid syndrome. Eur J Med Genet
2023;66:104763. DOI PubMed
89. Serrada-Tejeda S, Martínez-Piédrola RM, Máximo-Bocanegra N, Sánchez-Herrera-Baeza P, Pérez-de-Heredia-Torres M. Descriptive
analysis of adaptive behavior in Phelan-McDermid syndrome and autism spectrum disorder. Front Neurosci 2022;16:893003. DOI
PubMed PMC
90. Droogmans G, Vergaelen E, Van Buggenhout G, Swillen A. Stressed parents, happy parents. An assessment of parenting stress and
family quality of life in families with a child with Phelan-McDermid syndrome. J Appl Res Intellect Disabil 2021;34:1076-88. DOI
PubMed
91. Jacob S, Anagnostou E, Hollander E, et al. Large multicenter randomized trials in autism: key insights gained from the balovaptan
clinical development program. Mol Autism 2022;13:25. DOI PubMed PMC